DIVA Labs. Business Summary

DIVA Laboratories, Ltd. (4153.TWO) is a specialized Taiwan-based manufacturer of high-precision medical and industrial display solutions. The company generates revenue primarily through the design, manufacturing, and sale of medical-grade visualization systems, including DICOM-compliant radiology monitors, endoscopic and surgical imaging displays, and touch-enabled human-machine interface (HMI) products. Its business model is heavily anchored in high-value Original Design Manufacturing (ODM) and Original Equipment Manufacturing (OEM) partnerships with global healthcare leaders such as Philips and GE Healthcare, complemented by its own branded product lines. DIVA’s primary business segments are categorized into Medical Displays, which serve diagnostic and surgical environments, and Industrial Displays, which focus on specialized embedded and ruggedized applications. Within the global market, DIVA competes directly with major players such as Barco, EIZO, Sony, and Advantech, positioning itself as a high-agility specialist that delivers customized, high-resolution imaging solutions for critical healthcare infrastructure. Founded in 1994, DIVA Laboratories is led by a veteran executive team with extensive experience in medical electronics and imaging technology. Chief Executive Officer Kuo Sen Chen, who has served in his role since 2002, has been the primary architect of the company’s transition into the specialized medical display sector. The current leadership team includes Chief Financial Officer Chia Fen Chiang (appointed 2017) and Chief Technology Officer Chien Hsun Yang (appointed 2020), who directs the firm’s research and development efforts in 4K/8K resolution and AI-integrated diagnostic tools. Publicly listed on the Taipei Exchange (TPEx), the company maintains a stable governance structure with a board of directors that oversees strategic expansions into hybrid operating room technologies. Its shareholder base is characterized by a mix of institutional investors and corporate backers, reflecting its established role as a critical tier-one supplier in the international medical device supply chain.